BLOOD RESEARCH

Quick links

Most Cited Most Read Ahead of Print Archives Go to E-submission

Archives

Archives

Vol.54 No.3, September 30, 2019

PerspectiveSeptember 30, 2019

1 2339 1142

Optimizing carfilzomib use in multiple myeloma treatment

Sung-Soo Yoon, M.D., Ph.D.
Blood Res 2019; 54(3): 159-161
Image of HematologySeptember 30, 2019

1 1612 551

Chronicles of blood morphology associated with steroid use

Kavita Gaur, Vandana Puri, Shailaja Shukla, Sunita Sharma
Blood Res 2019; 54(3): 162-162
Image of HematologySeptember 30, 2019

0 1774 1093

A case of follicular lymphoma accompanied with chylous ascites

Masashi Ohe, Masaru Baba, Haruki Shida, Ken Furuya, Katsuhisa Kogawa
Blood Res 2019; 54(3): 163-163
Image of HematologySeptember 30, 2019

2 1282 472

Neutrophil-erythrocyte rosettes in direct antiglobulin test-negative autoimmune hemolytic anemia

Hee Sue Park, Kyeong Seob Shin, Bo Ra Son
Blood Res 2019; 54(3): 164-164
Review ArticleSeptember 30, 2019

40 4818 1622

Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts

Ezzatollah Fathi, Zohreh Sanaat, Raheleh Farahzadi
Blood Res 2019; 54(3): 165-174
Original ArticleSeptember 30, 2019

12 3662 926

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study

Duo Huang, Emmanuel Wong, Ming-Liang Zuo, Pak-Hei Chan, Wen-Sheng Yue, Hou-Xiang Hu, Ling Chen, Li-Xue Yin, Xin-Wu Cui, Ming-Xiang Wu, Xi Su, Chung-Wah Siu, Jo-Jo Hai
Blood Res 2019; 54(3): 175-180
Original ArticleSeptember 30, 2019

12 3266 1163

HIV/AIDS-related lymphoma: perspective from a regional cancer center in India

A.H. Rudresha, Pravin Ashok Khandare, D. Lokanatha, Abraham Jacob Linu, M.C. Suresh Babu, K.N. Lokesh, L.K. Rajeev, Carol Saldanha Smitha, Vaibhav Baburao Amale, C.S. Premalata, Mulchandani Nikita
Blood Res 2019; 54(3): 181-188
Original ArticleSeptember 30, 2019

0 3032 1121

Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD

Dong Won Baek, Jung Min Lee, Ju-Hyung Kim, Hee Jeong Cho, Ji-Yeon Ham, Jang-Soo Suh, Sang-Kyun Sohn, Joon Ho Moon
Blood Res 2019; 54(3): 189-197
Original ArticleSeptember 30, 2019

3 2457 628

Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients

Chur Woo You, Hee Jo Baek, Sang Kyu Park, Young Shil Park, Ho-Jin Shin, Werner Engl, Srilatha Tangada
Blood Res 2019; 54(3): 198-203
Original ArticleSeptember 30, 2019

9 3770 1221

The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A

Ju Young Kim, Chur Woo You
Blood Res 2019; 54(3): 204-209

1
2

Blood Res

Volume 59 2024

Current Issue Archives

Archives

2020s
2010s
2000s
1990s
1980s
1970s
1960s

2024
2023
2022
2021
2020

2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

2009
2008
2007
2006
2005
2004
2003
2002
2001
2000

1999
1998
1997
1996
1995
1994
1993
1992
1991
1990

1989
1988
1987
1986
1985
1984
1983
1982
1981
1980

1979
1978
1977
1976
1975
1974
1973
1972
1971
1970

1969
1968
1967
1966

Apr. Vol. 58 No. S1.

Mar. Vol. 58 No. 1. 1~82

Jun. Vol. 58 No. 2. 83~124

Sep. Vol. 58 No. 3. 125~164

Dec. Vol. 58 No. 4. 165~245

Apr. Vol. 57 No. S1.

Mar. Vol. 57 No. 1. 1~84

Jun. Vol. 57 No. 2. 85~171

Sep. Vol. 57 No. 3. 173~246

Dec. Vol. 57 No. 4. 247~297

Apr. Vol. 56 No. S1.

Mar. Vol. 56 No. 1. 1~58

Jun. Vol. 56 No. 2. 59~123

Sep. Vol. 56 No. 3. 125~207

Dec. Vol. 56 No. 4. 209~353

Jul. Vol. 55 No. S1.

Mar. Vol. 55 No. 1. 1~69

Jun. Vol. 55 No. 2. 71~128

Sep. Vol. 55 No. 3. 129~189

Dec. Vol. 55 No. 4. 191~282

Mar. Vol. 54 No. 1. 1~79

Jun. Vol. 54 No. 2. 81~158

Sep. Vol. 54 No. 3. 159~240

Dec. Vol. 54 No. 4. 241~295

Mar. Vol. 53 No. 1. 1~94

Jun. Vol. 53 No. 2. 95~182

Sep. Vol. 53 No. 3. 183~264

Dec. Vol. 53 No. 4. 265~336

Mar. Vol. 52 No. 1. 1~76

Jun. Vol. 52 No. 2. 77~150

Sep. Vol. 52 No. 3. 151~233

Dec. Vol. 52 No. 4. 235~339

Mar. Vol. 51 No. 1. 1~68

Jun. Vol. 51 No. 2. 69~147

Sep. Vol. 51 No. 3. 149~214

Dec. Vol. 51 No. 4. 215~299

Mar. Vol. 50 No. 1. 1~65

Jun. Vol. 50 No. 2. 67~121

Sep. Vol. 50 No. 3. 123~185

Dec. Vol. 50 No. 4. 187~267

Mar. Vol. 49 No. 1. 1~73

Jun. Vol. 49 No. 2. 75~137

Sep. Vol. 49 No. 3. 139~207

Dec. Vol. 49 No. 4. 209~285

Mar. Vol. 48 No. 1. 1~69

Jun. Vol. 48 No. 2. 71~163

Sep. Vol. 48 No. 3. 165~234

Dec. Vol. 48 No. 4. 235~303

Mar. Vol. 47 No. 1. 1~82

Jun. Vol. 47 No. 2. 85~156

Sep. Vol. 47 No. 3. 157~238

Dec. Vol. 47 No. 4. 239~310

Mar. Vol. 46 No. 1. 1~58

Jun. Vol. 46 No. 2. 59~144

Sep. Vol. 46 No. 3. 145~208

Dec. Vol. 46 No. 4. 209~288

Mar. Vol. 45 No. 1. 1~75

Jun. Vol. 45 No. 2. 77~140

Sep. Vol. 45 No. 3. 143~212

Dec. Vol. 45 No. 4. 215~285

Mar. Vol. 44 No. 1. 1~65

Jun. Vol. 44 No. 2. 67~126

Sep. Vol. 44 No. 3. 127~197

Dec. Vol. 44 No. 4. 199~340

Mar. Vol. 43 No. 1. 1~66

Jun. Vol. 43 No. 2. 69~124

Sep. Vol. 43 No. 3. 127~201

Dec. Vol. 43 No. 4. 203~279

Mar. Vol. 42 No. 1. 1~70

Jun. Vol. 42 No. 2. 71~179

Sep. Vol. 42 No. 3. 181~300

Dec. Vol. 42 No. 4. 301~443

Mar. Vol. 41 No. 1. 1~70

Jun. Vol. 41 No. 2. 73~136

Sep. Vol. 41 No. 3. 139~223

Dec. Vol. 41 No. 4. 225~326

Mar. Vol. 40 No. 1. 1~62

Jun. Vol. 40 No. 2. 65~132

Sep. Vol. 40 No. 3. 135~208

Dec. Vol. 40 No. 4. 211~282

Mar. Vol. 39 No. 1. 1~54

Jun. Vol. 39 No. 2. 59~117

Sep. Vol. 39 No. 3. 127~199

Dec. Vol. 39 No. 4. 209~261

Mar. Vol. 38 No. 1. 1~76

Jun. Vol. 38 No. 2. 81~150

Sep. Vol. 38 No. 3. 157~216

Dec. Vol. 38 No. 4. 221~278

Mar. Vol. 37 No. 1. 1~87

Jun. Vol. 37 No. 2. 89~167

Sep. Vol. 37 No. 3. 169~240

Dec. Vol. 37 No. 4. 259~311

Mar. Vol. 36 No. 1. 1~104

Jun. Vol. 36 No. 2. 105~179

Sep. Vol. 36 No. 3. 181~273

Dec. Vol. 36 No. 4. 275~363

Mar. Vol. 35 No. 1. 1~96

Jun. Vol. 35 No. 2. 97~194

Sep. Vol. 35 No. 3. 195~306

Mar. Vol. 34 No. 1. 1~162

Jun. Vol. 34 No. 2. 189~354

Sep. Vol. 34 No. 3. 359~511

Dec. Vol. 34 No. 4. 513~650

Mar. Vol. 33 No. 1. 48~145

Jun. Vol. 33 No. 2. 171~299

Sep. Vol. 33 No. 3. 303~474

Mar. Vol. 32 No. 1. 22~156

Jun. Vol. 32 No. 2. 203~328

Sep. Vol. 32 No. 3. 333~494

Mar. Vol. 31 No. 1. 61~180

Jun. Vol. 31 No. 2. 211~356

Sep. Vol. 31 No. 3. 359~505

Mar. Vol. 30 No. 1. 39~160

Jun. Vol. 30 No. 2. 197~342

Sep. Vol. 30 No. 3. 345~507

Mar. Vol. 29 No. 1. 1~116

Jun. Vol. 29 No. 2. 171~254

Sep. Vol. 29 No. 3. 259~380

Mar. Vol. 28 No. 1. 1~194

Jun. Vol. 28 No. 2. 241~440

Mar. Vol. 27 No. 1. 1~199

Jun. Vol. 27 No. 2. 227~451

Mar. Vol. 26 No. 1. 1~217

Jun. Vol. 26 No. 2. 245~461

Mar. Vol. 25 No. 1. 1~309

Jun. Vol. 25 No. 2. 327~610

Mar. Vol. 24 No. 1. 1~278

Jun. Vol. 24 No. 2. 301~562

Mar. Vol. 23 No. 1. 1~289

Jun. Vol. 23 No. 2. 313~533

Mar. Vol. 22 No. 1. 1~182

Jun. Vol. 22 No. 2. 205~417

Mar. Vol. 21 No. 1. 1~138

Jun. Vol. 21 No. 2. 169~346

Mar. Vol. 20 No. 1. 5~172

Jun. Vol. 20 No. 2. 199~371

Mar. Vol. 19 No. 1. 5~175

Jun. Vol. 19 No. 2. 207~395

Mar. Vol. 18 No. 1. 3~147

Jun. Vol. 18 No. 2. 169~281

Mar. Vol. 17 No. 1. 3~90

Jun. Vol. 17 No. 2. 115~221

Mar. Vol. 16 No. 1. 3~48

Jun. Vol. 16 No. 2. 71~161

Mar. Vol. 15 No. 1. 3~67

Jun. Vol. 15 No. 2. 87~147

Mar. Vol. 14 No. 1. 3~100

Mar. Vol. 13 No. 1. 1~70

Jun. Vol. 13 No. 2. 89~141

Mar. Vol. 12 No. 1. 1~79

Jun. Vol. 12 No. 2. 97~171

Mar. Vol. 11 No. 1. 3~69

Mar. Vol. 10 No. 1. 3~83

Mar. Vol. 9 No. 1. 1~33

Mar. Vol. 8 No. 1. 1~41

Jun. Vol. 8 No. 2. 1~55

Mar. Vol. 7 No. 1. 1~52

Mar. Vol. 6 No. 1. 1~43

Jun. Vol. 6 No. 2. 53~116

Mar. Vol. 5 No. 1. 1~53

Mar. Vol. 4 No. 1. 1~37

Mar. Vol. 3 No. 1. 1~55

Mar. Vol. 2 No. 1. 1~54

Mar. Vol. 1 No. 1. 3~80

pISSN 2287-979X
eISSN 2288-0011

qr-code